Cycle Pharmaceuticals Launches Its First Oncology Product, PHYRAGO™ (dasatinib) Tablets, in the US

Cycle Pharmaceuticals announces the launch of PHYRAGO, its first oncology product in the US. PHYRAGO is launched in ...
TipRanks on MSN

Enliven, Novartis drugs poised to lead in CML markets, says Clear Street

After Novartis (NVS) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive ...
TipRanks on MSN

Novartis Scemblix receives positive CHMP opinion for Scemblix

Novartis (NVS) announced that the Committee for Medicinal Products for Human Use, CHMP, of the European Medicines Agency, EMA, has adopted a ...

Scots mum given weeks to live after shock leukaemia diagnosis on daughter's birthday

A Scots mum was given just weeks left to live after a shocking blood cancer diagnosis on her daughter's birthday. Elaine ...